(CARL)
NMS – Real Time Price. Currency in USD
9.66
-0.20 (-2.03%)
At close: Mar 27, 2026, 4:00 PM EDT
9.66
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
9.66
-0.20 (-2.03%)
At close: Mar 27, 2026, 4:00 PM EDT
9.66
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:10 PM EDT
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
| Name | Position |
|---|---|
| Mr. Jeff Bertolini | Senior Vice President of Operational Excellence |
| Mr. Leonard M. Greenstein J.D. | CFO & Treasurer |
| Mr. Michael John Cordonnier | Co-Founder, Chairman, CEO & President |
| Mr. Niall Patrick Casey J.D. | Co-Founder, Chief Intellectual Property Officer & Director |
| Mr. Shariq Hussain | Chief Technology Officer |
| Mr. William Durall | Chief Commercial Officer |
| Ms. Jenifer Kamocsay | Chief Legal Officer & Secretary |
| Date | Type | Document |
|---|---|---|
| 2026-01-12 | 8-K | carl-20260112.htm |
| 2025-11-06 | 8-K | carl-20251106.htm |
| 2025-10-30 | 8-K | carl-20251029.htm |
| 2025-08-28 | 10-Q | carl-20250630.htm |
| 2025-07-24 | S-8 | carl_s-8_initial_offer.htm |
| 2025-07-21 | 8-A12B | carl_8-a12b_july_2025.htm |
| 2025-07-18 | CORRESP | filename1.htm |
| 2025-07-15 | CORRESP | filename1.htm |
| 2025-07-07 | CORRESP | filename1.htm |
| 2025-06-26 | CORRESP | filename1.htm |
| Ms. Jodi Allen Coe M.B.A. |
| Senior Vice President of People & Culture |
| Ms. Julie Lamothe | Senior Vice President of Quality & Regulatory Affairs |
| Ms. Sharon V. Schulzki | Chief Clinical & Market Access Officer |